Anti-paternal lymphocyte antibodies: a modified cellular enzyme-linked immunospecific assay (CELISA)

D C Kilpatrick1, A J Kitchin, W A Liston

  • 1Dept of Transfusion Medicine, Royal Infirmary, Edinburgh, Scotland, UK.

Medical Laboratory Sciences
|March 1, 1992
PubMed

Insights

A new cellular enzyme-linked immunospecific assay accurately measures IgG antibodies after donor-specific lymphocyte infusions. This simple, sensitive, and specific method provides objective results for immune monitoring.

Area of Science:

  • Immunology
  • Assay Development
  • Transplantation Science

Background:

  • Monitoring immune responses is crucial in transplantation.
  • Donor-specific antibodies can impact transplant outcomes.
  • Existing methods for antibody detection may have limitations.

Purpose of the Study:

  • To describe a novel cellular enzyme-linked immunospecific assay.
  • To evaluate its suitability for measuring IgG antibody response to donor-specific lymphocyte infusions.

Main Methods:

  • Development of a cellular enzyme-linked immunospecific assay.
  • Application of the assay to detect IgG antibodies.
  • Assessment of assay sensitivity, specificity, and objectivity.

Main Results:

  • The described assay is ideally suited for measuring IgG antibody response.
  • The procedure is characterized by its simplicity.
  • The assay demonstrates high sensitivity and specificity.
  • Objective measurement of antibody response is achieved.

Conclusions:

  • A novel, simple, sensitive, specific, and objective assay for measuring IgG antibodies to donor-specific lymphocyte infusions has been developed.
  • This assay is well-suited for immune monitoring in transplantation settings.